Thursday, 17.9.2026
|
0830 - 0835 Theatersaal |
Opening of the SGG-SASL-SVEP congress Markus Heim, Basel |
|
0830 - 0835 Ballsaal |
Opening of the SGG-SASL-SVEP congress Markus Heim, Basel |
|
0830 - 0835 Auditorium |
Opening of the SGG-SASL-SVEP congress Markus Heim, Basel |
|
0835 - 1000 Auditorium |
Endoscopy I - Interventional EUS: meet the experts |
|
0835 - 0920 Auditorium |
Endosonographic gastroenterostomy Frans Olivier The and Nursing Team from Stadtspital Zürich, Zürich |
|
0940 - 1000 Auditorium |
EUS-directed biliary drainage Reiner Wiest and Nursing Team from Inselspital Bern, Bern |
|
0835 - 1000 Theatersaal |
Inflammatory Bowel Disease |
|
0835 - 0856 Theatersaal |
The IBDome Sebastian Zeissig, Bern |
|
0856 - 0917 Theatersaal |
Urgency and incontinence in IBD Thomas Greuter, Lugano |
|
0917 - 0938 Theatersaal |
Management of postoperative patients with IBD Tim Raine, Cambridge, UK |
|
0938 - 1000 Theatersaal |
Legacy drugs and their place in current IBD treatment Gerhard Rogler, Zürich |
|
0835 - 1000 Ballsaal |
New Challenges in Hepatology |
|
0835 - 0856 Ballsaal |
Hepatitis D: how to treat and for how long? Nasser Semmo, Bern |
|
0856 - 0917 Ballsaal |
Non-invasive testing: does etiology matter? Maja Thiele, Kopenhagen, Denmark |
|
0917 - 0938 Ballsaal |
Hepatitis E Darius Moradpour, Lausanne |
|
0938 - 1000 Ballsaal |
Evolving concepts in palliative care in advanced chronic liver disease Sumita Verma, Brighton, UK |
|
1000 - 1030 Exhibition Area |
Coffee break in the Exhibition Area |
|
1030 - 1200 Auditorium |
SGG-SASL-SVEP Joint Session - Cancer screening and surveillance |
|
1030 - 1052 Auditorium |
Colorectal cancer screening Antoni Castells, Barcelona, Spain |
|
1052 - 1114 Auditorium |
Barretts surveillance Sachin Wani, Denver, USA |
|
1114 - 1136 Auditorium |
Personalization of HCC surveillance Pierre Nahon, Bobigny, France |
|
1138 - 1200 Auditorium |
Liquid biopsy for cancer screening Klaus Pantel, Hamburg, Germany |
|
1200 - 1330 Exhibition Area |
Lunch break in the Exhibition Area |
|
1215 - 1245 Ballsaal |
Lunch Symposium Johnson&Johnson: Maintenance Matters: From Dark Matters to Deep Remission |
|
1215 - 1245 Theatersaal |
Lunch Symposium Eli Lilly |
|
1250 - 1320 Theatersaal |
Lunch Symposium Gilead Sciences Switzerland Sàrl: Managing PBC in Clinical Practice: Guideline, Evidence, Uncertainty, and Decision-Making Andreas Kremer, Zürich Montserrat Fraga, Lausanne |
|
1250 - 1320 Ballsaal |
Lunch Symposium Takeda Pharma AG: IBD in 2026: What’s the Verdict beyond Symptom Control? Luc Biedermann, Zürich Pascal Juillerat, Fribourg und Bern Sophie Restellini, Meyrin/Genève |
|
1330 - 1500 Auditorium |
The Evolving Landscape for Gastroenterologists, Hepatologists and GI Nurses |
|
1330 - 1352 Auditorium |
TARDOC und ambulante Pauschalen Ellen Utzinger, Wallisellen |
|
1352 - 1414 Auditorium |
Should Hepatology become an independent speciality or remain a subspeciality of Gastroenterology? David Semela, St. Gallen |
|
1414 - 1436 Auditorium |
Shortage of nursing staff in endoscopy Deepa Gandhi, Dublin, Ireland |
|
1438 - 1500 Auditorium |
Colon carcinoma screening programs in Switzerland: current status and outlook Alain Vonlaufen, Genève |
|
1330 - 1500 Theatersaal |
IBD oral presentations |
|
1330 - 1355 Theatersaal |
When could fecal transplantation be appropriate in IBD? Michael Scharl, Zürich |
|
1330 - 1500 Ballsaal |
Hepatology oral presentations I |
|
1330 - 1352 Ballsaal |
Clinical research in liver disease: from clinical reasoning to practice-changing evidence Annalisa Berzigotti, Bern |
|
1330 - 1500 Saal Brünig |
SVEP-ASPE: Handson-Workshop I |
|
1500 - 1530 Exhibition Area |
Coffee break in the Exhibition Area |
|
1500 - 1530 Kongresssaal |
Poster Walks Gastroenterology and Hepatology |
|
1530 - 1700 Auditorium |
IBD: meet the experts |
|
1530 - 1552 Auditorium |
Innovative Therapieansätze bei IBD Andrea Kreienbühl, Zürich |
|
1552 - 1614 Auditorium |
Transition in Theorie und Praxis Dimitri Rast, Basel |
|
1614 - 1634 Auditorium |
Transition: das Konzept und die Praxis: was sind die Herausforderungen? Mary-Louise Dali, Basel |
|
1638 - 1700 Auditorium |
Transition aus Sicht der Patientin / des Patienten |
|
1530 - 1700 Theatersaal |
Endoscopy oral presentations |
|
1530 - 1555 Theatersaal |
EUS biliary drainage - the end of ERCP? Christoph Schlag, Zürich |
|
1530 - 1700 Ballsaal |
Rare Liver Diseases Session |
|
1530 - 1552 Ballsaal |
Presentation of Rare-Liver Network Andreas Kremer, Zürich |
|
1552 - 1614 Ballsaal |
Polycystic Liver Disease Frederik Nevens, Leuven, Belgium |
|
1616 - 1636 Ballsaal |
Alagille Syndrome Björn Fischler, Stockholm, Sweden |
|
1638 - 1700 Ballsaal |
Wilsons Disease Piotr Socha, Warszawa, Poland |
|
1530 - 1700 Saal Brünig |
SVEP-ASPE: Handson-Workshop II |
|
1715 - 1800 Auditorium |
General Assembly SVEP-ASPE |
|
1715 - 1800 Theatersaal |
General Assembly SGGSSG |
|
1800 - 1845 Saal Brünig |
General Assembly IBDnet |
|
1800 - 1845 Theatersaal |
General Assembly SASL |
|
1800 - 1845 Ballsaal |
General Assembly MDL |
|
1800 - 1845 Saal Harder |
General Assembly Swiss NGM |
Friday, 18.9.2026
|
0745 - 0815 Theatersaal |
Early Bird Symposium MSD: Precision Begins Early – Gastroenterology at the Frontline of GI Oncology |
|
0830 - 1000 Auditorium |
Endoscopy II - Third space endoscopy: meet the experts |
|
0830 - 0915 Auditorium |
POEM Henriette Heinrich, Basel |
|
0915 - 1000 Auditorium |
G-POEM Léon Finci, Genève |
|
0830 - 1000 Theatersaal |
Gastroenterology Update 2026 |
|
0830 - 0852 Theatersaal |
Pancreatic neuroendocrine tumors: management and prognosis Sébastien Godat, Lausanne |
|
0852 - 0914 Theatersaal |
Wireless recording in funtional intestinal disease Mark Fox, Arlesheim |
|
0914 - 0936 Theatersaal |
Computational modelling in intestinal diagnosis Niko Beerenwinkel, Zürich |
|
0938 - 1000 Theatersaal |
Use of AI in gastroenterology Cesare Hassan, Milano, Italy |
|
0830 - 1000 Ballsaal |
Hepatology Hot Topics 2026 |
|
0830 - 0852 Ballsaal |
MASLD: the endocrinologist point of view to a rational approach in the era of GLP1RA Cyrielle Caussy, Lyon, France |
|
0852 - 0914 Ballsaal |
Portal Hypertension in 2026: a summary of the Baveno VIII consensus conference Thomas Reiberger, Wien, Austria |
|
0914 - 0936 Ballsaal |
Endohepatology: Indications, challenges and opportunities Ilaria Tarantino, Palermo, Italy |
|
0938 - 1000 Ballsaal |
Managing Cholestatic Pruritus in 2026: Where Do IBATs Fit? Andreas Kremer, Zürich |
|
1000 - 1030 Exhibition Area |
Coffee break in the Exhibition Area |
|
1030 - 1200 Auditorium |
SGG-SASL-SVEP Joint Session - Best in Science, Practice and Care and Prize Winner Talks |
|
1030 - 1055 Auditorium |
Extracorporeal liver support using xenogeneic pig livers: Progress, Challenges, and Clinical Prospects Abraham Shaked, Pennsylvania, USA |
|
1055 - 1105 Auditorium |
Hepatology Prize 2026 |
|
1105 - 1130 Auditorium |
State of the art: How to resect large polyps in the colon? Michael Bourke, Sydney, Australia |
|
1130 - 1140 Auditorium |
Gastroenterology Prize 2026 |
|
1140 - 1200 Auditorium |
Nursing Roles in Caring for Patients with Crohn\'s Disease or Ulcerative Colitis Palle Bager, Aarhus, Denmark |
|
1200 - 1330 Exhibition Area |
Lunch break in the Exhibition Area |
|
1215 - 1245 Theatersaal |
Lunch Symposium AbbVie: Switch or No-Switch? Ultrasound-Guided Therapy Decisions in IBD Thomas Greuter, Lugano Sebastian Zeissig, Bern Sophie Restellini, Meyrin/Genève |
|
1215 - 1245 Ballsaal |
Lunch Symposium Schwabe Pharma |
|
1250 - 1320 Ballsaal |
Lunch Symposium Ipsen Pharma Schweiz GmbH: Seeing the Unseen: Uncovering Genetic Cholestatic Diseases in Everyday Hepatology Practice Andreas Kremer, Zürich Valérie McLin, Genève |
|
1330 - 1500 Auditorium |
Functional Gastroenterology |
|
1330 - 1352 Theatersaal |
Global prevalence, characterization and impact of Functional Bowel Disorders Tom Van Gils, Göteborg, Sweden |
|
1352 - 1414 Auditorium |
Pathophysiological Mechanisms of Functional Gastrointestinal Disorders Vassilis Pachnis, London, UK |
|
1414 - 1436 Auditorium |
Personalized Management Strategies in Functional Gastrointestinal Disorders Giovanni Barbara, Bologna, Italy |
|
1438 - 1500 Auditorium |
The role of manometry, impedance and FLIP in diagnosis and classification of functional GI disorders Sabine Roman, Lyon, France |
|
1330 - 1500 Theatersaal |
Gastroenterology oral presentations |
|
1330 - 1355 Theatersaal |
Management of pancreatic cysts Reiner Wiest, Bern |
|
1330 - 1500 Ballsaal |
Hepatology oral presentations II |
|
1330 - 1355 Ballsaal |
Machine perfusion Philipp Dutkowski, Basel |
|
1500 - 1530 Exhibition Area |
Coffee break in the Exhibition Area |
|
1530 - 1700 Auditorium |
Tour de Suisse 2026 - Tips and tricks for daily clinical practice |
|
1530 - 1540 Auditorium |
How do I do hepaticgastrostomy Sébastien Godat, Lausanne |
|
1540 - 1550 Auditorium |
How do I start and maintain immunosuppression in autoimmune hepatitis Benedetta Terziroli Beretta-Piccoli, Lugano |
|
1550 - 1600 Auditorium |
How do I diagnose and treat functional dyspepsia? Daniel Pohl, Zürich |
|
1600 - 1610 Auditorium |
How to I do a colo-enterostomy |
|
1610 - 1620 Auditorium |
Therapy of Wilsons disease: How do I choose and dose the drug, and how do I monitor and adjust the therapy? Montserrat Fraga, Lausanne |
|
1630 - 1640 Auditorium |
How to prepare a patient psychologically for liver transplantation |
|
1640 - 1650 Auditorium |
How do I dilate esophageal stenosis in EOE? Alain Schoepfer, Lausanne |
|
1650 - 1700 Auditorium |
MASLD: What are the most efficient lifestyle advices? David Semela, St. Gallen |
|
1530 - 1700 Theatersaal |
Young Gastroenterologists |
|
1530 - 1700 Ballsaal |
Abdominal Sonography Course (SGUM accreditated) |